{
    "root": "31295cea-5cb4-ef0c-e063-6294a90a1298",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ROPIVACAINE HYDROCHLORIDE",
    "value": "20250325",
    "ingredients": [
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "ROPIVACAINE HYDROCHLORIDE",
            "code": "V910P86109"
        }
    ],
    "indications": "ropivacaine hydrochloride injection indicated production local regional anesthesia surgery acute pain management . surgical anesthesia : epidural block surgery including cesarean section ; major nerve block ; local infiltration . acute pain management : epidural continuous infusion intermittent bolus , e.g . , postoperative labor ; local infiltration",
    "contraindications": "table 1 recommendations . ( 2.2 )",
    "warningsAndPrecautions": "ropivacaine hydrochloride injection , usp clear colorless , preservative-free solution , available single-dose containers 2 mg/ml ( 0.2 % ) , 5 mg/ml ( 0.5 % ) , 10 mg/ml ( 1 % ) concentrations . storage solutions stored 20ºc 25°c ( 68 ºf 77 °f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . ropivacaine hydrochloride injection , usp single dose vials product code unit sale strength 033 ndc 83854-013-25 unit 25 0.2 % 40 mg per 20 ml ( 2 mg per ml ) ndc 83854-013-01 20 ml single dose vial 035 ndc 83854-014-05 unit 5 0.5 % 150 mg per 30 ml ( 5 mg per ml ) ndc 83854-014-01 30 ml single dose vial 036 ndc 83854-015-25 unit 25 1 % 200 mg per 20 ml ( 10 mg per ml ) ndc 83854-015-01 20 ml single dose vial ropivacaine hydrochloride injection container closure made natural rubber latex . single dose - discard unused portion .",
    "adverseReactions": "ropivacaine hydrochloride contraindicated patients known hypersensitivity ropivacaine local anesthetic agent amide type .",
    "indications_original": "Ropivacaine Hydrochloride Injection is indicated for the production of local or regional anesthesia for surgery and for acute pain management.\n                  \n                     Surgical Anesthesia: epidural block for surgery including cesarean section; major nerve block; local infiltration.\n\n \n                  \n                     Acute Pain Management: epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration",
    "contraindications_original": "See Table 1 for Dosage Recommendations. ( 2.2 )",
    "warningsAndPrecautions_original": "Ropivacaine Hydrochloride Injection, USP is a clear colorless, and preservative-free solution, available in single-dose containers in 2 mg/mL (0.2%), 5 mg/mL (0.5%), and 10 mg/mL (1%) concentrations.\n                  Storage\n                  Solutions should be stored at 20ºC to 25°C (68 ºF to 77 °F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].\n                  Ropivacaine Hydrochloride Injection, USP Single Dose Vials\n                  \n                     \n                        \n                           \n                              \n                                 Product Code\n                              \n                           \n                           \n                              \n                                 Unit of Sale\n                              \n                           \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 Each\n                              \n                           \n                        \n                        \n                           \n                              033\n                           \n                           \n                              NDC 83854-013-25\n                              Unit of 25\n                           \n                           \n                              0.2%\n                              40 mg per 20 mL (2 mg per mL)\n                           \n                           \n                              NDC 83854-013-01\n                              20 mL single dose vial\n                           \n                        \n                        \n                           \n                              035\n                           \n                           \n                              NDC 83854-014-05\n                              Unit of 5\n                           \n                           \n                              0.5%\n                              150 mg per 30 mL (5 mg per mL)\n                           \n                           \n                              NDC 83854-014-01\n                              30 mL single dose vial\n                           \n                        \n                        \n                           \n                              036\n                           \n                           \n                              NDC 83854-015-25\n                              Unit of 25\n                           \n                           \n                              1%\n                              200 mg per 20 mL (10 mg per mL)\n                           \n                           \n                              NDC 83854-015-01\n                              20 mL single dose vial\n                           \n                        \n                     \n                  \n                  Ropivacaine Hydrochloride injection container closure is not made with natural rubber latex.\n                  Single Dose Only - Discard unused portion.",
    "adverseReactions_original": "Ropivacaine Hydrochloride is contraindicated in patients with a known hypersensitivity to ropivacaine or to any local anesthetic agent of the amide type."
}